BRTH — Breathe BioMedical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Breathe BioMedical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -3.97 | -4.46 | -8.36 |
| Depreciation | |||
| Non-Cash Items | 0.708 | 0.617 | 2.35 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.292 | 0.655 | 0.535 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -2.75 | -2.93 | -5.09 |
| Capital Expenditures | -0.754 | -0.604 | -0.128 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 1.78 | 0 | 0 |
| Change in Net Investments | |||
| Cash from Investing Activities | 1.02 | -0.604 | -0.128 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.72 | 3.38 | 6.31 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.007 | -0.147 | 1.09 |